Health Care
Commentary
Medicaid reform is popular
Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
Commentary
Price Controls Won’t End Global Pharma Freeloading
A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Commentary
Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Blog
Counting the Cost of Single-Payer
Sen. Bernie Sanders, I-Vt., is back on the road promoting Medicare for All. “We are the only major nation on earth that does not guarantee health care to all people as a human right,” he complained in a recent speech in Nevada. But the Vermont senator failed to explain how ...
Commentary
Democrats in Calif. Put Healthcare of Illegal Residents First
Free healthcare doesn’t come cheap. That’s one lesson Gov. Gavin Newsom, D-Calif., is learning the hard way. Since Newsom officially extended the state’s Medicaid program, Medi-Cal, to all undocumented immigrants last year, the entitlement’s costs have ballooned. Read the op-ed here.
Commentary
Big savings can be found in improper Medicare spending
Republicans are searching for ways to eliminate “fraud, waste, and abuse” in Medicaid, the federal-state entitlement created to provide health coverage for low-income, pregnant, homeless, and disabled people. It’s long past time. According to a new report from the Paragon Health Institute’s Brian Blase and the Economic Policy Innovation Center’s ...
Blog
Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field
The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Commentary
Social Needs-Based Medicaid a Costly, Useless ATM
Earlier this month, the Trump administration rescinded the Biden-era guidance for states on how to get the federal government to pay for “health-related social needs” via Medicaid. The guidance stretched the definition of “healthcare” to absurd lengths. Are carpet replacement and tenant-rights education healthcare? The Biden administration thought so. Read ...
Commentary
The Future of Healthcare Under Donald Trump
On this episode of All Things, Sally Pipes–healthcare aficionado and author of “The World’s Medicine Chest”–lays out the risks of Joe Biden’s coming drug price controls, the need to cut billions in waste and fraud from Medicaid, the fading chances for replacing ObamaCare, and the upsides and downsides of some ...
Commentary
Bernie Sanders Is Back. That’s Bad News For American Healthcare.
Is Bernie Sanders back? Earlier this month, the Associated Press proclaimed that Sanders has emerged as one of the leaders of a revived “anti-Trump resistance.” The 83-year-old senator is touring the country, “drawing huge crowds” who come to hear him talk about democracy, education, and health care. Read the op-ed ...
Medicaid reform is popular
Congressional Republicans keep dodging questions about cuts to Medicaid, the federal-state entitlement that covers nearly 80 million people. But they should not be shy about their plans to reform the entitlement. New polling shows that many of the GOP’s ideas for Medicaid aren’t just smart policy. They’re popular. A survey ...
Price Controls Won’t End Global Pharma Freeloading
A new paper by the America First Policy Institute, a think tank with close ties to the Trump administration, has revived the debate over global drug pricing. The paper points out that patients in the United States tend to pay considerably more for brand-name prescription drugs than those in most ...
Here’s How Trump’s Pick To Lead The FDA Can Supercharge The Agency
The U.S. Senate last week confirmed former Johns Hopkins surgeon and professor Dr. Marty Makary to lead the Food and Drug Administration. During his confirmation hearing, Makary said his goals for the agency were “more cures and meaningful treatments for Americans.” Throughout the hearing, he offered insight on how he ...
Counting the Cost of Single-Payer
Sen. Bernie Sanders, I-Vt., is back on the road promoting Medicare for All. “We are the only major nation on earth that does not guarantee health care to all people as a human right,” he complained in a recent speech in Nevada. But the Vermont senator failed to explain how ...
Democrats in Calif. Put Healthcare of Illegal Residents First
Free healthcare doesn’t come cheap. That’s one lesson Gov. Gavin Newsom, D-Calif., is learning the hard way. Since Newsom officially extended the state’s Medicaid program, Medi-Cal, to all undocumented immigrants last year, the entitlement’s costs have ballooned. Read the op-ed here.
Big savings can be found in improper Medicare spending
Republicans are searching for ways to eliminate “fraud, waste, and abuse” in Medicaid, the federal-state entitlement created to provide health coverage for low-income, pregnant, homeless, and disabled people. It’s long past time. According to a new report from the Paragon Health Institute’s Brian Blase and the Economic Policy Innovation Center’s ...
Imposing Price Controls on U.S. Drugs Won’t Level the Playing Field
The cost of capital for developing a new drug is $2.9 billion, including post approval research and development costs. Meanwhile, the process to develop a drug takes 10 years and only 12 percent of drugs make it to market. These costs do not change simply because governments impose price controls ...
Social Needs-Based Medicaid a Costly, Useless ATM
Earlier this month, the Trump administration rescinded the Biden-era guidance for states on how to get the federal government to pay for “health-related social needs” via Medicaid. The guidance stretched the definition of “healthcare” to absurd lengths. Are carpet replacement and tenant-rights education healthcare? The Biden administration thought so. Read ...
The Future of Healthcare Under Donald Trump
On this episode of All Things, Sally Pipes–healthcare aficionado and author of “The World’s Medicine Chest”–lays out the risks of Joe Biden’s coming drug price controls, the need to cut billions in waste and fraud from Medicaid, the fading chances for replacing ObamaCare, and the upsides and downsides of some ...
Bernie Sanders Is Back. That’s Bad News For American Healthcare.
Is Bernie Sanders back? Earlier this month, the Associated Press proclaimed that Sanders has emerged as one of the leaders of a revived “anti-Trump resistance.” The 83-year-old senator is touring the country, “drawing huge crowds” who come to hear him talk about democracy, education, and health care. Read the op-ed ...
